| |
Scope and purpose
The purpose of the International Journal of Pediatric Otorhinolaryngology is to concentrate and
disseminate information concerning prevention, cure and care of otorhinolaryngological disorders in infants and children due to developmental,
degenerative, infectious, neoplastic, traumatic, social, psychiatric and economic causes. The Journal provides a medium for clinical
and basic contributions in all of the areas of pediatric otorhinolaryngology. This includes medical and surgical otology, bronchoesophagology,
laryngology, rhinology, diseases of the head and neck, and disorders of communication, including voice, speech and language disorders.
Published in cooperation with the Asociacion Argentina de Otorrinolaringología y Fonoaudiología Pediátrica, the
Association Fran aise d'Otorhinolaryngologie P diatrique, the Australasian Society of Paediatric Oto-Rhino-Laryngology, the British Association
for Paediatric Otorhinolaryngology, the Dutch/Flemish Working Group for Pediatric Otorhinolaryngology, the European Society for Pediatric
Otorhinolaryngology, the Interamerican Association of Pediatric Otorhinolaryngology, the Italian Society of Pediatric Otorhinolaryngology,
the Japan Society for Pediatric Otorhinolaryngology, the Polish Society of Pediatric Otorhinolaryngology, and the Society for Ear, Nose
and Throat Advances in Children.
Submission of manuscripts
Manuscripts Submission and peer review of all papers is now
conducted entirely online, increasing efficiency for editors, authors, and reviewers, and enhancing publication speed. Submit online
at: http://ees.elsevier.com/ijporl Authors are guided stepwise through the entire process, and are kept abreast of the
progress of their paper at each stage.
The system creates PDF version of the submitted manuscript for peer review, revision and
proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.
Authors requesting
further information on online submission are strongly encouraged to view the system, including a tutorial, at http://ees.elsevier.com/ijporl.
For queries, please contact the journal editorial office directly: pedot@elsevier.com
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition
of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content,
(3) final approval of the version to be submitted.
On submission, all authors of the paper listed should sign a letter in which they
state they have all participated sufficiently in the conception and design of the work, in the analysis of the data and in writing the
manuscript to take public responsibility for it. If accepted, the manuscript shall not be published elsewhere in the same form, in either
the same or another language, without the consent of the Editors and publisher.
Acknowledgements
All contributors
who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might
be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general
support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
Conflict
of interest
The potential for conflict of interest exists when an author (or the author's institution), reviewer or editor has financial
or personal relationships that may inappropriately influence his or her actions. Editors and reviewers for the journal are responsible
for disclosing to the Editor-in-Chief any personal or financial relationship that may bias their work during the peer review process.
Authors are specifically asked to reflect on financial conflicts of interest (such as employment, consultancy, stock ownership, honoraria
and paid expert testimony) as well as other forms of conflict of interest, including personal, academic and intellectual issues.
At
the end of the text, under a subheading "Conflict of interest statement" all authors must disclose any financial and personal relationships
with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest
include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or
other funding.
Role of the funding source
All sources of funding should be declared as an acknowledgement at the end
of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation
of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no
such involvement, the authors should so state.
Randomised controlled trials
All randomised controlled trials submitted
for publication in International Journal of Pediatric Otorhinolaryngology should include a completed Consolidated Standards
of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at http://www.consort-statement.org
for more information. International Journal of Pediatric Otorhinolaryngology has adopted the proposal from the International
Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration
in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number
should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research study that
prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health
outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs,
surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any
biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely
observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not
require registration. Further information can be found at http://www.icmje.org
Disclosure of Clinical Trial Results
In line with the position of the International Committee of Medical Journal Editors , the journal will not consider results posted in
the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in
the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (eg, investors'
meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries
of results of the same or closely related work.
Patient Consent
Studies on patients or volunteers require ethics committee
approval and informed consent which should be documented in your paper.
Patients have a right to privacy. Therefore identifying
information, including patients images, names, initials, or hospital numbers, should not be included in videos, recordings, written
descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed
consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such
consent is made subject to any conditions, Elsevier must be made aware of all such conditions. Written consents must be provided to
Elsevier on request.
Even where consent has been given, identifying details should be omitted if they are not essential. If identifying
characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do
not distort scientific meaning and editors should so note.
If such consent has not been obtained, personal details of patients included
in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.
For further information see Patient details.
Ethics
Work on human beings that is submitted to IJPORL should comply with the principles laid down in the Declaration of
Helsinki; Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly,
Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly,
Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript should contain a statement
that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that
subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with
institution guidelines. Patients' and volunteers' names, initials, and hospital numbers should not be used.
Copyright
Accepted papers become the copyright of the Journal and are accepted on the understanding that they have not been published, are not
being considered for publication elsewhere and are subject to editorial revision. If papers closely related to the submitted manuscript
have been published or submitted for publication elsewhere, the author must state this in their cover letter Upon acceptance of an article,
authors will be asked to sign a "Journal Publishing Agreement" (for more information on this and copyright see http://www.elsevier.com/authors).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form.
If excerpts from other copyrighted
works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier
has pre printed forms for use by authors in these cases: e-mail healthpermissions@elsevier.com. Requests may also be completed
online via the Elsevier homepage at Permissions.
Language Editing
Papers will only be accepted when they are written in an acceptable standard of English. Authors who require
information about language editing and copyediting services pre- and post-submission please visit Language Editing Services
or contact authorsupport@elsevier.com for more information. Please note Elsevier neither
endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising.
For more information please refer to our Terms
and Conditions.
(Authors in Japan please note: Upon request, Elsevier Ltd Japan will provide authors with a list of people
who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Ltd, Japan, 9-15,
Higashi-Azabu 1-chome, Minato-ku, Tokyo 106-0044; Japan; Tel: (+81)3-5561-5032; Fax: (+81)3-5561-5045; E-mail: info@elsevier.co.jp
Manuscripts
As a rule Papers, Review Articles and Case Reports should be divided into sections headed
by a caption (e.g. Introduction, Methods, Results, Discussion, and Acknowledgements, etc.).
The abstract is essential and
the most read part of the paper. The abstract should be informative, not descriptive, and should be free of abbreviations except for
units of measure. The abstract should be on a separate file. An abstract for an original article not exceed 350 words and should be structured
into four paragraphs: (1) Objective: should concisely describe (a) the problem addressed in the study and (b) the purpose(s) of
the study, (2) Methods: explains concisely how the study was performed (basic procedures with study material and observational
and analytical methods). (3) Results: should describe the main finding with specific data and their statistical significance,
if possible. (4) Conclusions: contains the principal conclusions of the study. Abstracts for case reports should not exceed 100
words and should not have a structured format. Following the abstract, up to 6 keywords are to be given for subject indexing. They should
be taken from Index Medicus or composed on similar lines.
If illustrations or other small parts of articles or books already published
elsewhere are used in papers submitted to the International Journal of Pediatric Otorhinolaryngology, the written permission
of author and publisher concerned must be included with the manuscript. The original source must be indicated in the legend of the illustration
in these cases.
Authors' full names, academic or professional affiliations, and complete addresses should be included on
a separate title page. The name and address of the author to whom proofs and correspondence are to be sent should be given.
Case Reports
Please note that henceforth case reports will only be accepted for International Journal of Pediatric Otorhinolaryngology,
where they contain substantial new data of exceptional interest. All other case reports of value for continuing medical education purposes
will be automatically considered for IJPORL
EXTRA. International Journal of Paediatric Otorhinolaryngology EXTRA
a separate online-only publication dedicated
to continuing medical education including case reports.
References
(1) All publications cited in the text should be
presented in a list of references following the text of the manuscript. The manuscript should be carefully checked to ensure that the
spellings of authors' names are exactly the same in the text and in the list of references. Authors are responsible for the accuracy
and completeness of their references and for correct text citation.
(2) References should be numbered consecutively in the order
in which they are first mentioned. In the text they should be cited with Arabic numerals between square brackets. For listing references,
follow the JAMA style, abbreviating names of journals according to Index Medicus. List all authors/editors but if there are more than
six, list the first six plus et al.
Examples:
[1] Froehlich P, Seid AB, Morgon A. Contrasting strategic approaches
to the management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol 1996;36:137-146.
[2] Kambic V, Gale N. Epithelial Hyperplastic
Lesions of the Larynx. Amsterdam: Elsevier, 1995.
[3] Marcus R,Couston AM, Water-soluble vitamins: the vitamin B complex and ascorbic
acid. In:Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New
York: Pergamon Press, 1990;1530-1552.
Statistics
Describe statistical methods with enough detail to enable a knowledgeable
reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate
indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing,
such as the use of P values, which fails to convey important information about effect size. References for the design of the study and
statistical methods should be to standard works when possible (with pages stated). Define statistical terms, abbreviations, and most
symbols. Specify the computer software used.
Illustrations
Figures of good quality should be submitted online as a separate
file. For detailed instructions on the preparation of electronic artwork, consult: http://www.elsevier.com/authors. Permission
to reproduce illustrations should always be obtained before submission and details included with the captions.
Tables
Tables of numerical data should each be typed (also with double spacing) on a separate file, numbered in sequence in Arabic numerals
(Table 1, 2, etc.), provided with a heading, and referred to in the text as Table 1, Table 2, etc.
Proofs
One set of
page proofs in PDF format will be sent by e-mail to the corresponding author which they are requested to correct and return within 48
hours. Only minor corrections are acceptable at this stage. If we do not have an e-mail address then paper proofs will be sent by post.
Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from Adobe. Instructions on how to annotate PDF files will
accompany the proofs. The exact system requirements are given at the Adobe
site.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and
return to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post.
Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article
via e-mail or, alternatively, 25 free paper offprints. The PDF file is a watermarked version of the published article and includes a
cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional paper offprints can be
ordered by the authors. An order form with prices will be sent to the corresponding author.
Accepted Articles
Visit http://authors.elsevier.com/TrackPaper.html for the facility to track accepted articles and set email alerts to inform you of
when an article's status has changed. There are also details of artwork guidelines, copyright information, frequently asked questions
and more. Contact details for questions arising after acceptance of an article, especially those related to proofs, are provided after
registration of an article for publication.
Funding body agreements and policies
Elsevier has established agreements
and developed policies to allow authors who publish in Elsevier journals to comply with potential manuscript archiving requirements as
specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
Editorial office
To contact the International Journal of Pediatic Otorhinolaryngology editorial office, please
email PEDOT@elsevier.com. We aim to respond to all queries rapidly.
|
| |
|
